Style | Citing Format |
---|---|
MLA | Faghihi H, et al.. "The Effect of Freeze-Dried Antibody Concentrations on Its Stability in the Presence of Trehalose and Hydroxypropyl-Β-Cyclodextrin: A Box–Behnken Statistical Design." Pharmaceutical Development and Technology, vol. 22, no. 6, 2017, pp. 724-732. |
APA | Faghihi H, Khalili F, Amini M, Vatanara A (2017). The Effect of Freeze-Dried Antibody Concentrations on Its Stability in the Presence of Trehalose and Hydroxypropyl-Β-Cyclodextrin: A Box–Behnken Statistical Design. Pharmaceutical Development and Technology, 22(6), 724-732. |
Chicago | Faghihi H, Khalili F, Amini M, Vatanara A. "The Effect of Freeze-Dried Antibody Concentrations on Its Stability in the Presence of Trehalose and Hydroxypropyl-Β-Cyclodextrin: A Box–Behnken Statistical Design." Pharmaceutical Development and Technology 22, no. 6 (2017): 724-732. |
Harvard | Faghihi H et al. (2017) 'The Effect of Freeze-Dried Antibody Concentrations on Its Stability in the Presence of Trehalose and Hydroxypropyl-Β-Cyclodextrin: A Box–Behnken Statistical Design', Pharmaceutical Development and Technology, 22(6), pp. 724-732. |
Vancouver | Faghihi H, Khalili F, Amini M, Vatanara A. The Effect of Freeze-Dried Antibody Concentrations on Its Stability in the Presence of Trehalose and Hydroxypropyl-Β-Cyclodextrin: A Box–Behnken Statistical Design. Pharmaceutical Development and Technology. 2017;22(6):724-732. |
BibTex | @article{ author = {Faghihi H and Khalili F and Amini M and Vatanara A}, title = {The Effect of Freeze-Dried Antibody Concentrations on Its Stability in the Presence of Trehalose and Hydroxypropyl-Β-Cyclodextrin: A Box–Behnken Statistical Design}, journal = {Pharmaceutical Development and Technology}, volume = {22}, number = {6}, pages = {724-732}, year = {2017} } |
RIS | TY - JOUR AU - Faghihi H AU - Khalili F AU - Amini M AU - Vatanara A TI - The Effect of Freeze-Dried Antibody Concentrations on Its Stability in the Presence of Trehalose and Hydroxypropyl-Β-Cyclodextrin: A Box–Behnken Statistical Design JO - Pharmaceutical Development and Technology VL - 22 IS - 6 SP - 724 EP - 732 PY - 2017 ER - |